Cargando…
No aggravation of congenital thrombotic thrombocytopenic purpura by mRNA-based vaccines against COVID-19: a Japanese registry survey
Autores principales: | Hamada, Eriko, Sakai, Kazuya, Yamada, Shinya, Kubo, Masayuki, Hayakawa, Masaki, Matsumoto, Masanori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8814789/ https://www.ncbi.nlm.nih.gov/pubmed/35119501 http://dx.doi.org/10.1007/s00277-022-04774-2 |
Ejemplares similares
-
ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
por: Sakai, Kazuya, et al.
Publicado: (2022) -
Distinguishing immune-mediated thrombotic thrombocytopenic purpura from septic disseminated intravascular coagulation using plasma levels of haptoglobin and factor XIII activity
por: Yamada, Shinya, et al.
Publicado: (2023) -
Clinical Manifestations, Current and Future Therapy, and Long-Term Outcomes in Congenital Thrombotic Thrombocytopenic Purpura
por: Sakai, Kazuya, et al.
Publicado: (2023) -
Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023) -
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023
por: Matsumoto, Masanori, et al.
Publicado: (2023)